drugset / Trial / NCT00002400

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

NCT00002400

Completed 45 enrolled Pharmacia and Upjohn
Treatment

Summary

The purpose of this study is to compare the safety and effectiveness of giving HIV-infected patients delavirdine (DLV) plus zidovudine (ZDV) plus 2 doses of indinavir (IDV) or ZDV plus IDV plus lamivudine (3TC). This study also examines how the body processes DLV when it is given in combination with other drugs.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Delavirdine Small molecule
Subject INDINAVIR ANHYDROUS Other / unclassified
Subject Lamivudine Other / unclassified
Subject Zidovudine Small molecule